✦ LIBER ✦

Rejection rates in a randomised trial of tacrolimus monotherapy versus triple therapy in liver transplant recipients with hepatitis C virus cirrhosis

✍ Scribed by D.N. Samonakis; M. Mela; A. Quaglia; C.K. Triantos; U. Thalheimer; G. Leandro; A. Pesci; M.L. Raimondo; A.P. Dhillon; K. Rolles; B.R. Davidson; D.W. Patch; A.K. Burroughs

Book ID: 110904054
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 163 KB
Volume: 8
Category: Article
ISSN: 1398-2273
DOI: 10.1111/j.1399-3062.2006.00124.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outcome of recurrent hepatitis C virus a

Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy

✍ Pinelopi Manousou; Dimitrios Samonakis; Evangelos Cholongitas; David Patch; Jame 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB 👁 2 views

Less potent immunosuppression is considered to reduce the severity of hepatitis C virus (HCV) recurrence after liver transplantation. An optimal regimen is unknown. We evaluated tacrolimus monotherapy versus triple therapy in a randomized trial of 103 first transplants for HCV cirrhosis. One hundred

Reply: Outcome of recurrent hepatitis C

Reply: Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy

✍ Dinesh Jothimani; Timothy J. S. Cross 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB 👁 1 views

We read with interest the article by Manousou and colleagues, 1 investigating the impact of tacrolimus monotherapy (MT) versus triple therapy (TT) on recurrent hepatitis C infection after liver transplantation. This study examined hepatic fibrosis progression in patients randomized to tacrolimus MT

Impact of tacrolimus versus cyclosporine

Impact of tacrolimus versus cyclosporine in hepatitis C virus-infected liver transplant recipients on recurrent hepatitis: A prospective, randomized trial

✍ Paul Martin; Ronald W. Busuttil; Robert M. Goldstein; Jeffrey S. Crippin; Goran 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

Hepatitis C virus (HCV)-induced cirrhosis is the commonest indication for orthotopic liver transplantation, but HCV recurrence is nearly universal and may worsen patient / graft outcomes. The frequency and severity of HCV recurrence has apparently increased in recent years, raising concern about a p

A prospective randomized trial comparing

A prospective randomized trial comparing tacrolimus and steroids with tacrolimus monotherapy in liver transplantation: the impact on recurrence of hepatitis C

✍ Carlos Margarit; Itxarone Bilbao; Lluis Castells; Iñigo Lopez; Leonor Pou; Elena 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 137 KB

Long-term histological effects of preemp

Long-term histological effects of preemptive antiviral therapy in liver transplant recipients with hepatitis C virus infection

✍ Alexander Kuo; Vivian Tan; Billy Lan; Mandana Khalili; Sandy Feng; John P. Rober 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB

The long-term effects of preemptive antiviral therapy on fibrosis progression in liver transplant recipients with hepatitis C virus (HCV) were examined in a cohort of consecutive liver transplant recipients who received preemptive antiviral therapy for 48 weeks (95% were virologic nonresponders). Co

Prediction of sustained virological resp

Prediction of sustained virological response in liver transplant recipients with recurrent hepatitis C virus following combination pegylated interferon alfa-2b and ribavirin therapy using tissue hepatitis C virus reverse transcriptase polymerase chain reaction testing

✍ Guy W. Neff; Christopher B. O'Brien; Robert Cirocco; Marzia Montalbano; Maria de 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 2 views

The optimal duration of therapy for pegylated interferon combined with ribavirin in recurrent Hepatitis C virus (HCV) following liver transplantation is not known. We wanted to determine if testing for HCV in liver tissue by reverse transcriptase polymerase chain reaction (RT-PCR) was superior in pr